menu
    • menu

    Company profile for Elpiscience

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Elpiscience is an immunology-driven company that develops cutting-edge immunotherapies to fight cancer. Science-focused, Elpiscience is led by a team of top-notch executives whose diverse experiences span from managing global pharma strategy to establishing biotech companies in China. Capitalizing on regional strength and global partnerships, Elpiscience has developed a pipeline of over 10 innovative molecules including two IN...
    Elpiscience is an immunology-driven company that develops cutting-edge immunotherapies to fight cancer. Science-focused, Elpiscience is led by a team of top-notch executives whose diverse experiences span from managing global pharma strategy to establishing biotech companies in China. Capitalizing on regional strength and global partnerships, Elpiscience has developed a pipeline of over 10 innovative molecules including two IND filing ready assets targeting novel pathways in cancer immunotherapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ElpiscienceChina Flag
    Country
    Country
    China
    Address
    Address
    781 Cailun Rd., Suite 501, Pudong, Shanghai, 201203
    Telephone
    Telephone
    (+86) 21 50651310
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.elpiscience.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Elpiscience and Astellas Enter into Research Collaboration
    Elpiscience and Astellas Enter into Research Collaboration

    29 Dec 2023

    // PRESS RELEASE

    https://www.astellas.com/en/news/28816

    PRESS RELEASE
    29 Dec 2023
    Share Share
    Elpiscience Announces Studies Presented at SITC 2023 Annual Meeting
    Elpiscience Announces Studies Presented at SITC 2023 Annual Meeting

    05 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231105346235/en

    BUSINESSWIRE
    05 Nov 2023
    Share Share
    Elpiscience Announces First Patient Dosed for Phase 1 Trial of Anti-LILRB2
    Elpiscience Announces First Patient Dosed for Phase 1 Trial of Anti-LILRB2

    26 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230926810623/en

    BUSINESSWIRE
    26 Sep 2023
    Share Share
    Elpiscience Announces First Patient Dosed for Phase 1 Trial of Antibody ES014
    Elpiscience Announces First Patient Dosed for Phase 1 Trial of Antibody ES014

    27 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230227005064/en

    BUSINESSWIRE
    27 Feb 2023
    Share Share
    Elpiscience to Present Its Novel Immunotherapies during J.P. Morgan Week 2023
    Elpiscience to Present Its Novel Immunotherapies during J.P. Morgan Week 2023

    04 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230104005423/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share
    Elpiscience Announces Studies Presented at SITC 2022 Annual Meeting
    Elpiscience Announces Studies Presented at SITC 2022 Annual Meeting

    21 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221118005140/en

    BUSINESSWIRE
    21 Nov 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search